Researchers find links between heart trouble, stroke

ProteoMonitor tells us about some fascinating research going on between scientists at Thermo Fisher Scientific's BRIMS Center and Massachusetts General Hospital to identify protein biomarkers linked to stroke.

The group is exploring the relationship between strokes and patent foramen ovale, which is a congenital heart defect. Everybody is born with this opening between the left and right chambers of the heart. But if it fails to close soon after birth, the hole is called patent foramen ovale. ProteoMonitor reports that a phenotype that results from this opening could allow a blood clot to travel to the brain and possibly cause a stroke.

The group, led in part by MingMing Ning, a scientist at MGH's Clinical Proteomics Research Center, is trying to identify protein markers to guide doctors' use of tissue plasminogen activator in stroke treatment, according to ProteoMonitor.

"It's not just the brain itself that's the problem," Ning told ProteoMonitor. Key to better understanding the disease is to "better understand the signaling between the heart and the brain," she said. The researchers hope the BRIMS biomarker work will help them better understand this signaling.

- read the article in ProteoMonitor
- and learn more about MingMing Ning's research

Suggested Articles

The drug that treats atrial fibrillation, flecainide, has been around since the '80s. Grace Colón, CEO of InCarda, thinks it needs a face-lift.

3M, maker of the ubiquitous Littmann stethoscope brand, has teamed up with Eko to create a new digital version that amplifies sounds and adds AI.

Study data from Medtronic showed more patients reported improvements in their chronic back pain after treatments with the devicemaker’s tiny implant.